Abivax
(ABVX.FP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,100 | 707 | 309 | 156 | 66 |
| Accounts receivable | 4,591 | -14,231 | 240 | -2,560 | 2,656 |
| Accounts payable and accrued liabilities | -3,444 | 31,757 | 6,865 | N/A | N/A |
| Other Working Capital | 1,423 | 21,266 | 7,221 | -1,414 | 9,666 |
| Other Operating Activity | -157,742 | -136,629 | -42,624 | -41,839 | -42,211 |
| Operating Cash Flow | $-154,072 | $-97,130 | $-27,989 | $-45,657 | $-29,823 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -640 | -265 | -30 | -1,330 | -282 |
| Purchase Of Investment | N/A | -9,351 | -470 | -126 | -294 |
| Sale Of Investment | N/A | 741 | N/A | N/A | 0 |
| Purchase Sale Intangibles | -3 | 0 | -13 | N/A | N/A |
| Other Investing Activity | 16,405 | 780 | 0 | 0 | 1 |
| Investing Cash Flow | $15,762 | $-8,095 | $-513 | $-1,456 | $-575 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 47,944 | 55,841 | 14,950 | 25,000 | 26,948 |
| Debt Repayment | -10,458 | -40,602 | -3,597 | -11,954 | -3,414 |
| Common Stock Issued | 434 | 353,387 | 28,592 | 65,466 | 26,395 |
| Other Financing Activity | -9,713 | -33,336 | 8,088 | 0 | 0 |
| Financing Cash Flow | $28,207 | $335,290 | $48,033 | $78,512 | $49,929 |
| Exchange Rate Effect | 2,382 | -5,072 | N/A | N/A | N/A |
| Beginning Cash Position | 251,942 | 26,950 | 9,771 | 29,302 | 9,771 |
| End Cash Position | 144,221 | 251,942 | 29,302 | 60,701 | 29,302 |
| Net Cash Flow | $-110,103 | $230,064 | $19,531 | $31,399 | $19,531 |
| Free Cash Flow | |||||
| Operating Cash Flow | -154,072 | -97,130 | -27,989 | -45,657 | -29,823 |
| Capital Expenditure | -643 | -265 | -43 | -1,642 | -898 |
| Free Cash Flow | -154,715 | -97,395 | -28,032 | -47,299 | -30,721 |